PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access

In their closing remarks, the panel shares their view on the future of prescription digital therapeutics and the prospects for the widespread adoption and implementation of these therapeutics in health care systems.

Video content above is prompted by the following questions:

  1. How can payers work with providers to establish protocols for appropriate PDT prescribing and monitoring efficacy?
  2. What opportunities exist for collaborative demonstration projects across payers, providers, manufacturers, and other stakeholders to generate evidence on optimal implementation strategies?
  3. How might PDTs potentially help mitigate or reduce healthcare disparities and inequities in access to treatment or health outcomes across different populations?
  4. How important is it that Congress pass the Access to Prescription Digital Therapeutics Actas you consider the long-term value PDTs can have on improving care to patients? 
Related Videos
A panel of 5 experts on RSV
A panel of 5 experts on RSV
A panel of 4 experts on CLL
A panel of 4 experts on CLL
Related Content
CH LogoCenter for Biosimilars Logo